PSNRESEARCH
Daniele Enotarpi has a diverse and extensive work experience. Daniele is currently serving as the Chief Executive Officer at Hippocrates Research - Innovative SME since March 2021. Prior to this, they held the roles of Group CEO and Owner at Hippocrates Holding srl, where they provided biotechnological services and regulatory support. As a Partner and Founder, they were involved in the establishment of Soter IT Security. Daniele also served as the Chief Executive Officer at Next Future Research and Hippocrates Research, leading research and development in the pharmaceutical and healthcare industries. Additionally, they were the Regional Office Director at PSNRESEARCH, overseeing the design and implementation of clinical protocols. Moreover, they served as the Chief Executive Officer at Hippocrates Pharma Genetics, specializing in personalized therapy and genetic research. Daniele was the CEO of Hippocrates Sintech and Co-Owner of Nyali Swiss. Furthermore, Daniele Enotarpi served as the President of Agenzia Trasporto Pubblico Locale - Liguria, providing guidance and management in public transportation.
Daniele Enotarpi received a Diploma in Maturità Scientifica from Liceo Scientifico G.P. Vieusseux from 1975 to 1980. Daniele then pursued a degree in Medicina e Chirurgia at Università degli Studi di Genova from 1981 to 1988. After that, they obtained a Borsa di Studio at IRCCS INRCA - Fondazione Biancalana Masera from 1990 to 1992.
This person is not in any offices
PSNRESEARCH
PSNRESEARCH is a full-service global Contract Research Organization (CRO) with over 500 employees in 15 offices across Northern & Southern America, Europe and Australia. They offer superior clinical development services to biotechnology, pharmaceutical companies and independent institutions acting as sponsors who wish to have a dedicated and cost effective partner.